BH3-only proteins Bid and BimEL are differentially involved in neuronal dysfunction in mouse models of Huntington's disease

Journal of Neuroscience Research

Volumn 85, Issue 12, 2007, Pages 2756-2769

  García Martínez, Juan M ^a   Pérez Navarro, Esther ^a   Xifró, Xavier ^a   Canals, Josep M ^a   Díaz Hernández, Miguel ^b   Trioulier, Yael ^c   Brouillet, Emmanuel ^c   Lucas, José J ^b   Alberch, Jordi ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

BDNF; HD94 mice; R6 1 mice; Striatum

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; PROTEIN BID;

ANIMAL MODEL; APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUNTINGTON CHOREA; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CELL SURVIVAL; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUNTINGTON DISEASE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 34548361756     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21258     Document Type: Conference Paper

References (59)

1. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A. 2005. p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47:29-41.
2. Bates GP, Harper PS, Jones AL. 2002. Huntington's disease. Oxford: Oxford University Press.
3. Beal MF. 2000. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23:298-304.
4. Benn SC, Woolf CJ. 2004. Adult neuron survival strategies - slamming on the brakes. Nat Rev Neurosci 5:686-700.
5. Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N, DiFiglia M. 1996. Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523-5535.
6. Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J. 2004. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24:7727-7739.
7. Cory S, Adams JM. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656.
8. de la Monte SM, Vonsattel JP, Richardson EP Jr. 1988. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47:516-525.
9. Diaz-Hernandez M, Torres-Peraza J, Salvatori-Abarca A, Moran MA, Gomez-Ramos P, Alberch J, Lucas JJ. 2005. Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. J Neurosci 25:9773-9781.
10. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E. 1995. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6:1053-1057.
11. Ernfors P, Lee KF, Jaenisch R. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150.
12. Eskelinen EL, Tanaka Y, Saftig P. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13:137-145.
13. Fletcher JI, Huang DC. 2006. BH3-only proteins: orchestrating cell death. Cell Death Differ 13:1268-1271.
14. Galas MC, Bizat N, Cuvelier L, Bantubungi K, Brouillet E, Schiffmann SN, Blum D. 2004. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. Neurobiol Dis 15:152-159.
15. Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De MJ, MacDonald ME, Lessmann V, Humbert S, Saudou F. 2004. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127-138.
16. Gines S, Bosch M, Marco S, Gavalda N, Diaz-Hernandez M, Lucas JJ, Canals JM, Alberch J. 2006. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Eur J Neurosci 23:649-658.
17. Gozuacik D, Kimchi A. 2004. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891-2906.
18. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. 2004. Survival factor-induced extracellular signal-regulated kinase phosphorylates Bim, inhibiting its association with Bax and proapoptotic activity. Proc Natl Acad Sci U S A 101:15313-15317.
19. Huang DC, Strasser A. 2000. BH3-only proteins - essential initiators of apoptotic cell death. Cell 103:839-842.
20. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
21. Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, DiFiglia M. 2000. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20:7268-7278.
22. Krajewska M, Zapata JM, Meinhold-Heerlein I, Hedayat H, Monks A, Bettendorf H, Shabaik A, Bubendorf L, Kallioniemi OP, Kim H, Reifenberger G, Reed JC, Krajewski S. 2002. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia 4:129-140.
23. Ley R, Ewings KE, Hadfield K, Cook SJ. 2005. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12:1008-1014.
24. Li L, Prevette D, Oppenheim RW, Milligan CE. 1998. Involvement of specific caspases in motoneuron cell death in vivo and in vitro following trophic factor deprivation. Mol Cell Neurosci 12:157-167.
25. Li SH, Li XJ. 2004. Huntingtin and its role in neuronal degeneration. Neuroscientist 10:467-475.
26. Li Z, Zhang J, Liu Z, Woo C-W, Thiele CJ. 2006. Down-regulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not ectoposide or cisplatin-induced cell death. Cell Death Differ [E-pub ahead of print].
27. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157.
28. MacDonald V, Halliday G. 2002. Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 10:378-386.
29. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
30. Mann DM, Oliver R, Snowden JS. 1993. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 85:553-559.
31. Martin JB, Gusella JF. 1986. Huntington's disease. Pathogenesis and management. N Engl J Med 315:1267-1276.
32. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A. 2000. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 157:449-461.
33. Perez-Navarro E, Gavalda N, Gratacos E, Alberch J. 2005. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. J Neurochem 92:678-691.
34. Petersen A, Mani K, Brundin P. 1999. Recent advances on the pathogenesis of Huntington's disease. Exp Neurol 157:1-18.
35. Polster BM, Fiskum G. 2004. Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 90:1281-1289.
36. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. 1995. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775-3787.
37. EL apoptotic function. J Biol Chem 281:813-823.
38. Rego AC, Oliveira CR. 2003. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28:1563-1574.
39. Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A. 2003. BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J Biol Chem 278:10707-10715.
40. Sawa A. 2001. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria? J Mol Med 79:375-381.
41. Sax JK, El-Deiry WS. 2003. p53 downstream targets and chemosensitivity. Cell Death Differ 10:413-417.
42. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL. 1993. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet 5:259-265.
43. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446.
44. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. 1995. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 133:265-272.
45. Torres-Peraza J, Pezzi S, Canals JM, Gavalda N, Garcia-Martinez JM, Perez-Navarro E, Alberch J. 2007. Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N-methyl-D-aspartate receptors. Neuroscience 144:462-471.
46. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME. 2000. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799-2809.
47. Vis JC, Schipper E, de Boer-van Huizen RT, Verbeek MM, de Waal RM, Wesseling P, ten Donkelaar HJ, Kremer B. 2005. Expression pattern of apoptosis-related markers in Huntington's disease. Acta Neuropathol 109:321-328.
48. Vonsattel JP, DiFiglia M. 1998. Huntington disease. J Neuropathol Exp Neurol 57:369-384.
49. Ward MW, Kogel D, Prehn JH. 2004. Neuronal apoptosis: BH3-only proteins the real killers? J Bioenerg Biomembr 36:295-298.
50. Ward MW, Rehm M, Duessmann H, Kacmar S, Concannon CG, Prehn JH. 2006. Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis. J Biol Chem 281:5837-5844.
51. Xifro X, Malagelada C, Minano A, Rodriguez-Alvarez J. 2005. Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis. Eur J Neurosci 21:827-840.
52. EL. J Biol Chem 277:41604-41612.
53. Yamamoto A, Lucas JJ, Hen R. 2000. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57-66.
54. Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. 2000. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290:1761-1765.
55. Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, Leavitt BR, Cattaneo E, Ferrante RJ, Hayden MR, Friedlander RM. 2003a. Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem 87:101-106.
56. Zhang Y, Ona VO, Li M, Drozda M, Dubois-Dauphin M, Przedborski S, Ferrante RJ, Friedlander RM. 2003b. Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease. J Neurochem 87:1184-1192.
57. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.
58. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E. 2001. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293:493-498.
59. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E. 2003. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76-83.